NT_1170x120_1-11-18

Scott Melville

CHPA names Dr. John Troup VP for scientific affairs and dietary supplements

CHPA names Dr. John Troup VP for scientific affairs and dietary supplements

WASHINGTON — The Consumer Healthcare Products Association (CHPA) announced the appointment of Dr. John Troup as vice president for scientific affairs and dietary supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs.

Pharmacy Outlook: Scott Melville, CHPA

Pharmacy Outlook: Scott Melville, CHPA

Welcome to 2020, where, more than ever, patients and caregivers are taking control of their health care decisions and an increasing array of consumer health care products is helping them get well, stay healthy, treat minor ailments and even manage some chronic conditions. The marketplace is evolving before our eyes, including the manufacturers, who are

Teen misuse of O-T-C cough medicine remains at historic lows

Teen misuse of O-T-C cough medicine remains at historic lows

WASHINGTON — The 2019 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released Wednesday showing that the number of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high decreased slightly, coming in at under 3%. When first reported in

CHPA names Beth Allgaier as a senior VP

CHPA names Beth Allgaier as a senior VP

WASHINGTON – The Consumer Healthcare Products Association (CHPA) announced that Beth Allgaier has been named senior vice president, business development and industry relations. Allgaier will be responsible for the association’s membership, education, and meetings functions, in addition to serving as chief liaison to the retail community. She will be a member of the association’s senior

CHPA petitions FDA to establish a clear path for CBD in dietary supplements

CHPA petitions FDA to establish a clear path for CBD in dietary supplements

WASHINGTON — The Consumer Healthcare Products Association (CHPA) submitted on Thursday a citizen petition to the U.S. Food and Drug Administration (FDA) urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol (CBD) in dietary supplements. “Intense consumer demand and commercial interest

House committee approves consumer health savings bill

House committee approves consumer health savings bill

WASHINGTON — The House Ways and Means Committee on Thursday took an important step toward reinstating consumers’ ability to purchase over-the-counter (O-T-C) medicines with tax-preferred savings accounts, including Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs). The Restoring Access to Medication Act (H.R. 1922), authored by Representatives Ron Kind (D, Wis.), Grace Meng (D

Texas signs age-restriction law to curb teen cough medicine abuse

Texas signs age-restriction law to curb teen cough medicine abuse

WASHINGTON — On May 17th, Texas Governor Greg Abbott signed into law an age-18 requirement for the purchase of over-the-counter (O-T-C) medicines containing the cough suppressant dextromethorphan (DXM), an ingredient which is abused by some teenagers to get high. Texas is the 19thstate to prohibit the sale of O-T-C cough medicine to minors, joining other

CHPA holds successful 2019 Annual Executive Conference

CHPA holds successful 2019 Annual Executive Conference

WASHINGTON – The Consumer Healthcare Products Association (CHPA) concluded their 2019 Annual Executive Conference, held from March 17-19, at the Boca Raton Resort and Club, in Boca Raton, Fla. More than 300 executives from the over-the-counter (OTC) drug, dietary supplement, and consumer medical device sectors heard from an impressive lineup of speakers, including renowned presidential historian and Pulitzer Prize-winning

Survey shows teen misuse of O-T-C cough medicine remains very low

Survey shows teen misuse of O-T-C cough medicine remains very low

WASHINGTON — The 2018 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that the percentage of teens using over-the-counter (O-T-C) cough medicine containing dextromethorphan (DXM) to get high remains at 3 %. When first reported in 2006, the number of teens abusing O-T-C cough medicines

CHPA welcomes new board members

CHPA welcomes new board members

WASHINGTON — New members of the Consumer Healthcare Products Association (CHPA) board of directors were elected at the association’s fall meeting, held November 14, in New York City. Gary Downing, chief executive officer, Clarion Brands, continues serving as CHPA’s board chairman. Newly elected CHPA board members at this meeting include: Paul Gama, vice president, North America

CHPA bullish on pending revision of O-T-C monograph policy

CHPA bullish on pending revision of O-T-C monograph policy

WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both

CHPA urges participation in supplement registry

CHPA urges participation in supplement registry

WASHINGTON — The Consumer Healthcare Products Association (CHPA) has called on members that market dietary supplements to submit product labels to the Supplement Online Wellness Library (OWL) developed by Council for Responsible Nutrition (CRN) and independent safety science firm UL. CRN said the announcement follows talks between CHPA and its Dietary Supplements Committee, which reviewed

Rx switches lead allergy sufferers to OTCs

Rx switches lead allergy sufferers to OTCs

WASHINGTON — More allergy sufferers are opting for over-the-counter medicines to alleviate their symptoms as more prescription products switch to OTC status, according to new research Consumer Healthcare Products Association (CHPA) and Nielsen. CHPA said Thursday the study found that 60% adult allergy sufferers use only OTCs for treatment, up from just more than half

Year of opportunity for OTC medicines

Year of opportunity for OTC medicines

The past year has brought much change, perhaps most evident in the recent national and local elections. As we welcome a new American president and Congress, the country is waiting to see how the regulatory and legislative landscape will evolve. But I am certain that one thing will not change: the continued importance of over-the-counter